Seeking Alpha
View as an RSS Feed

Justin M. Hall  

View Justin M. Hall's Articles BY TICKER:
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
    Sep. 11, 2009 BMY, PFE, OSIP 33 Comments
  • Five Drug Makers with Pending Catalysts
    Sep. 1, 2009 ALTH, ARIA, ENDP 55 Comments
  • SmartHeat: An Emerging Market Clean Energy Growth Play
    Aug. 27, 2009 HEAT 8 Comments
  • 'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers
    Aug. 25, 2009 FSYS, ONTY, TOMO 7 Comments
  • Spectrum Pharmaceuticals: The Labor Day Catalyst
    Aug. 20, 2009 SPPI, CTIC, BIIB 20 Comments
  • Ariad Pharmaceuticals: Significant Catalysts Approaching
    Aug. 14, 2009 ARIA, MRK, SGP 32 Comments
  • Spectrum Pharmaceuticals: Rumors of Buyout Talks Persist
    Aug. 10, 2009 SPPI, BYERF, BMY 24 Comments
  • These Small Cap Cancer Drugmakers Have Big Growth Potential
    Aug. 4, 2009 ONTY, MRK, ARIA 28 Comments
  • Spectrum Pharmaceuticals: Potential Acquisition Target
    Aug. 2, 2009 SPPI, BMY, BYERF 4 Comments
  • Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Results
    Jul. 29, 2009 ARIA, SPPI, ONTY 10 Comments
  • Spectrum Pharmaceuticals: Outlook Remains Very Promising
    Jul. 27, 2009 SPPI, ASTX, FSYS 22 Comments
  • Spectrum Pharmaceuticals and Zevalin: The Importance of FDA Approval
    Jul. 19, 2009 SPPI, BIIB, RHHBY 8 Comments
  • Spectrum Pharmaceuticals: Oversold and Undervalued
    Jul. 14, 2009 SPPI, CTIC 14 Comments
  • Spectrum Pharmaceuticals: Temporary Setback
    Jul. 6, 2009 SPPI, CTIC 9 Comments
  • 17 Reasons Why Bayer Might Acquire Spectrum Pharmaceuticals
    Jun. 30, 2009 SPPI 4 Comments
  • Spectrum Pharmaceuticals: Optimistic About Zevalin's Prospects
    Jun. 28, 2009 SPPI, BIIB, CTIC 6 Comments
  • Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
    Jun. 19, 2009 SPPI, AGN 19 Comments
  • Two Possible Upcoming Approvals for Spectrum Pharmaceuticals
    Jun. 12, 2009 SPPI 9 Comments